Polycystic ovarian syndrome

• 1967Clomiphene approved (FDA)

Trials started per year, stacked by phase (darker = later phase). Source: ClinicalTrials.gov via Clin2, which tracks studies recruiting in recent years — early years undercount.

Polycystic ovarian syndrome is a lifelong condition that can be managed. Treatments can modify key features: ovulation-induction agents like clomiphene help with infertility, while combined oral contraceptives, metformin, and lifestyle changes reduce hyperandrogenism and long-term metabolic risks. No approved therapy cures or prevents the syndrome in most people. The overall trajectory is stable, with no major shifts in outcomes over recent decades. The most important milestone remains the 1967 FDA approval of clomiphene, which opened the door to targeted fertility treatment. Research is active, with 143 trials started in the last five years, including 10 phase-3 studies, so the field is moving toward better options.

Can PCOS be cured?

No. Current treatments can manage symptoms, induce ovulation, and reduce long-term risks, but none cure the syndrome or prevent it in most people.

Does PCOS always cause infertility?

No. Many people with PCOS can conceive, sometimes with help. Ovulation-induction agents like clomiphene have been used since 1967 to improve fertility.

What is the most important treatment milestone?

The 1967 FDA approval of clomiphene. It was the first targeted therapy for ovulation problems and remains a cornerstone of fertility treatment in PCOS.

Is the outlook for PCOS improving?

Research is active, with 143 trials started in the last five years, including 10 phase-3 studies. But no major breakthrough has changed the overall trajectory yet.

Can lifestyle changes really help?

Yes. Lifestyle interventions are a standard part of management and can reduce hyperandrogenism and metabolic risks, though they are not a cure.